Paper · 12860416

Identification of a novel Ezrin-binding site in syndecan-2 cytoplasmic domain.

Granés F and 5 others. FEBS Lett, 2003. Cited by 52 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Identification of a novel Ezrin-binding site in syndecan-2 cytoplasmic domain. Papers, record 12860416. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12860416

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Identification of a novel Ezrin-binding site in syndecan-2 cytoplasmic domain.; PubMed
Journal: FEBS Lett; PubMed
Year: 2003; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/12860416/; PubMed
DOI: https://doi.org/10.1016/s0014-5793(03)00712-9; PubMed
The journal: https://conductscience.org/library/journal-index/0155157; PubMed
Citations, by iCite: 52; iCite
Relative citation ratio, by iCite: 0.96; iCite
Revised in PubMed: 2026-01-28; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Granés F	Francesc
2	Berndt C	Christine
3	Roy C	Christian
4	Mangeat P	Paul
5	Reina M	Manuel
6	Vilaró S	Senén

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Membrane Glycoproteins	Major topic
Phosphoproteins	Major topic
Proteoglycans	Major topic
Amino Acid Sequence
Binding Sites
Binding, Competitive
Cloning, Molecular
Cytoskeletal Proteins
Humans
Kinetics
Molecular Sequence Data
Peptide Fragments
Recombinant Fusion Proteins
Syndecan-2
Ezrin

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMID	Title	Journal	Year	In Papers	Source
41,152,817	Targeting syndecan-2 inhibits papillary thyroid cancer invasiveness and de-differentiation.	BMC Endocr Disord	2025	https://conductscience.org/library/papers/41152817	PubMed
39,913,561	The transmembrane protein Syndecan is required for stem cell survival and maintenance of their nuclear properties.	PLoS Genet	2025	https://conductscience.org/library/papers/39913561	PubMed
38,720,636	Genetic predictors for bacterial vaginosis in women living with and at risk for HIV infection.	Am J Reprod Immunol	2024	https://conductscience.org/library/papers/38720636	PubMed
37,371,090	Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis.	Cells	2023	https://conductscience.org/library/papers/37371090	PubMed
35,584,326	Targeting syndecan-1: new opportunities in cancer therapy.	Am J Physiol Cell Physiol	2022	https://conductscience.org/library/papers/35584326	PubMed
34,282,767	Syndecan-4 in Tumor Cell Motility.	Cancers (Basel)	2021	https://conductscience.org/library/papers/34282767	PubMed
34,213,535	The HSPG syndecan is a core organizer of cholinergic synapses.	J Cell Biol	2021	https://conductscience.org/library/papers/34213535	PubMed
33,669,066	Syndecans and Pancreatic Ductal Adenocarcinoma.	Biomolecules	2021	https://conductscience.org/library/papers/33669066	PubMed
33,178,691	Syndecan-4 Modulates Cell Polarity and Migration by Influencing Centrosome Positioning and Intracellular Calcium Distribution.	Front Cell Dev Biol	2020	https://conductscience.org/library/papers/33178691	PubMed
32,984,315	The Cardiac Syndecan-2 Interactome.	Front Cell Dev Biol	2020	https://conductscience.org/library/papers/32984315	PubMed

1 to 10 of 25

See all 25 cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
EZR	7,430	PubTator's text mining	https://conductscience.org/library/genes/7430	NCBI Gene
MSN	4,478	PubTator's text mining	https://conductscience.org/library/genes/4478	NCBI Gene
RDX	5,962	PubTator's text mining	https://conductscience.org/library/genes/5962	NCBI Gene
SDC2	6,383	PubTator's text mining	https://conductscience.org/library/genes/6383	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12860416

GET https://conductscience.org/api/papers/v1/12860416/cited_by?page=2

API reference For AI assistants